High USP30 levels enhance the proliferation, invasion, and migration capacities of HCC cells, positioning USP30 as a potential diagnostic and therapeutic target for liver cancer (Gu et al., 2018). This evidence concerns the gene USP30 and hepatocellular carcinoma.